 MELBOURNE, Australia and SAN FRANCISCO, Nov. 22, 2021 PRNewswire -- Alterity Therapeutics ASX: ATH, NASDAQ: ATHE Alterity or the Company, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that David Stamler, M.D., Chief Executive Officer will participate in two upcoming virtual investor events: MST Financial Lifesciences Biotech Fourm Wednesday, November 24 th at 5:20 p.m. 